Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Biofrontera Inc.

    NASDAQ: BFRIW · Real-Time Price · USD
    0.09
    -0.01 (-10.00%)
    At close: Jun 05, 2025, 3:16 PM
    0.09
    -0.11%
    After-hours: Jun 05, 2025, 04:00 PM EDT

    Biofrontera Statistics

    Share Statistics

    Biofrontera has 45.67M shares outstanding. The number of shares has increased by -1.62% in one year.

    Shares Outstanding

    n/a
    		 45.67M

    Shares Change (YoY)

    n/a
    		 -1.62%

    Shares Change (QoQ)

    n/a
    		 28.46%

    Owned by Institutions (%)

    n/a
    		 n/a

    Shares Floating

    n/a
    		 n/a

    Failed to Deliver (FTD) Shares

    n/a
    		 1,434

    FTD / Avg. Volume

    n/a
    		 9.54%

    Short Selling Information

    The latest short interest is 6.06K, so 0% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 6.06K

    Short % of Shares Out

    n/a
    		 n/a

    Short % of Float

    n/a
    		 n/a

    Short Ratio (days to cover)

    n/a
    		 1

    Valuation Ratios

    The PE ratio is -338.58 and the forward PE ratio is null. Biofrontera's PEG ratio is 3.39.

    PE Ratio

    n/a
    		 -338.58

    Forward PE

    n/a
    		 n/a

    PS Ratio

    n/a
    		 161.19

    Forward PS

    n/a
    		 0.1

    PB Ratio

    n/a
    		 1356.37

    P/FCF Ratio

    n/a
    		 -584.9

    PEG Ratio

    n/a
    		 3.39
    Financial Ratio History

    Enterprise Valuation

    Currently the Enterprise Value (EV) is not available for Biofrontera.

    EV / Sales

    n/a
    		 n/a

    EV / EBITDA

    n/a
    		 n/a

    EV / EBIT

    n/a
    		 n/a

    EV / FCF

    n/a
    		 n/a

    Financial Position

    The company has a current ratio of 1.72, with a Debt / Equity ratio of 1.11.

    Current Ratio

    n/a
    		 1.72

    Quick Ratio

    n/a
    		 1.17

    Debt / Equity

    n/a
    		 1.11

    Debt / EBITDA

    n/a
    		 -0.34

    Debt / FCF

    n/a
    		 -0.48

    Interest Coverage

    n/a
    		 -8.17

    Financial Efficiency

    Return on Equity is n/a and Return on Invested Capital is n/a.

    Return on Equity

    n/a
    		 n/a

    Return on Assets

    n/a
    		 n/a

    Return on Invested Capital

    n/a
    		 n/a

    Revenue Per Employee

    n/a
    		 $405,467.39

    Profits Per Employee

    n/a
    		 $-193,032.61

    Employee Count

    n/a
    		 92

    Asset Turnover

    n/a
    		 1.69

    Inventory Turnover

    n/a
    		 2.8

    Taxes

    Income Tax

    n/a
    		 22K

    Effective Tax Rate

    n/a
    		 -0.12%

    Stock Price Statistics

    The stock price has increased by 50.13% in the last 52 weeks. The beta is 0.3, so Biofrontera's price volatility has been higher than the market average.

    Beta

    n/a
    		 0.3

    52-Week Price Change

    n/a
    		 50.13%

    50-Day Moving Average

    n/a
    		 0.08

    200-Day Moving Average

    n/a
    		 0.05

    Relative Strength Index (RSI)

    n/a
    		 50.47

    Average Volume (20 Days)

    n/a
    		 15,029

    Income Statement

    In the last 12 months, Biofrontera had revenue of 37.3M and earned -17.76M in profits. Earnings per share was 0.

    Revenue

    n/a
    		 37.3M

    Gross Profit

    n/a
    		 18.7M

    Operating Income

    n/a
    		 -17.21M

    Net Income

    n/a
    		 -17.76M

    EBITDA

    n/a
    		 -14.44M

    EBIT

    n/a
    		 -15.63M

    Earnings Per Share (EPS)

    n/a
    		 0
    Full Income Statement

    Balance Sheet

    The company has 5.91M in cash and 4.92M in debt, giving a net cash position of 983K.

    Cash & Cash Equivalents

    n/a
    		 5.91M

    Total Debt

    n/a
    		 4.92M

    Net Cash

    n/a
    		 983K

    Retained Earnings

    n/a
    		 -117.41M

    Total Assets

    n/a
    		 16.59M

    Working Capital

    n/a
    		 4.37M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -10.27M and capital expenditures -10K, giving a free cash flow of -10.28M.

    Operating Cash Flow

    n/a
    		 -10.27M

    Capital Expenditures

    n/a
    		 -10K

    Free Cash Flow

    n/a
    		 -10.28M

    FCF Per Share

    n/a
    		 0
    Full Cash Flow Statement

    Margins

    Gross margin is 50.12%, with operating and profit margins of -46.14% and -47.61%.

    Gross Margin

    n/a
    		 50.12%

    Operating Margin

    n/a
    		 -46.14%

    Pretax Margin

    n/a
    		 -47.55%

    Profit Margin

    n/a
    		 -47.61%

    EBITDA Margin

    n/a
    		 -38.71%

    EBIT Margin

    n/a
    		 -46.14%

    FCF Margin

    n/a
    		 -27.56%

    Dividends & Yields

    BFRIW does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 n/a

    FCF Yield

    n/a
    		 n/a
    Dividend Details

    Analyst Forecast

    Currently there are no analyst rating for BFRIW.

    Price Target

    n/a
    		 n/a

    Price Target Difference

    n/a
    		 n/a

    Analyst Consensus

    n/a
    		 n/a

    Analyst Count

    n/a
    		 n/a
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Scores

    Altman Z-Score

    n/a
    		 -9.57

    Piotroski F-Score

    n/a
    		 3

    Add to Watchlist